Summary - Fundamenty - Všechna data pro vaši analýzu

Nástroje

Akciový screener

Kalendář zisků

Super investoři

Ostatní

Návod

IČ: 19940963

5. května 521, 501 01 Turnov

Zásady GDPR

Podmínky služby

Všechna práva vyhrazena @ 2024, Fundamenty.cz

Proudly created by draftspot.net

Day One Biopharmaceuticals, Inc.

DAWN

Valuace

Růst

Zdraví

Cena

$ 21.44

-0.34 (-3.24%)

Kapitalizace

1.0B

Obrat

Zisk

Aktiva

Dluh

ROE

-34%

ROA

-30%

-21

Cena 1R

6-14

⌀ Cena

7.51

Dividenda

0.0(0.0%)

Čtvrtletní 10-Q

Celoroční 10-K

Nadcházející oznámení zisků

Poslední dividenda

Profil

Biofarmaceutická společnost Day One Biopharmaceuticals, Inc. vyvíjí a komercializuje cílené terapie pro pacienty s geneticky definovanými nádory. Jeho hlavním kandidátem je DAY101, perorální inhibitor fibrosarkomkinázy typu II s rychlou akcelerací, který je v klinické studii fáze II pro dětské pacienty s relabujícím/progresivním gliomem nízkého stupně. Společnost také vyvíjí Pimasertib, perorální inhibitor malých molekul mitogenem aktivovaných proteinkinázových kináz 1 a 2. Společnost Day One Biopharmaceuticals, Inc. byla založena v roce 2018 a sídlí v jižním San Francisku v Kalifornii.

Sektor

Healthcare

Odvětví

Biotechnology

Počet zaměstnanců

181

Založení

2021-05-27

Adresa

395 Oyster Point Boulevard

CEO

Jeremy Bender

Web

dayonebio.com

Podobné společnosti

GERN

Geron Corporation

$ 1.11

+ $ 0.04

VALN

Valneva SE

$ 8.71

- $ 0.02

ARVN

Arvinas, Inc.

$ 11.24

+ $ 0.61

REPL

Replimune Group, Inc.

$ 8.66

+ $ 0.35

TYRA

Tyra Biosciences, Inc.

$ 14.36

+ $ 0.04

ERAS

Erasca, Inc.

$ 2.36

+ $ 0.09

VIR

Vir Biotechnology, Inc.

$ 5.36

+ $ 0.23

Zahraniční články

Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN

17:16 26-03-2026

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., ...

Day One Biopharmaceuticals Touts OJEMDA Sales Surge, Sets $225M-$250M 2026 Outlook at TD Cowen

1:07 11-03-2026

Day One Biopharmaceuticals (NASDAQ: DAWN) executives highlighted accelerating commercial momentum fo...

Are DAWN and TALK Obtaining Fair Deals for their Shareholders?

13:25 09-03-2026

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders....

DAWN Stock Jumps 66% on $2.5B Buyout Offer From Servier

10:11 09-03-2026

Day One's stock surges 66% after Servier agrees to acquire it for $21.50 per share in a $2.5B deal, ...

Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN

18:25 06-03-2026

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., ...

Stock Market Today, March 6: Energy Stocks Rise as Oil Closes Over $90 on Middle East Tensions

17:49 06-03-2026

The S&P 500 (^GSPC 1.33%) fell 1.33% to 6,740.02, the Nasdaq Composite (^IXIC 1.59%) slid 1.59% to 2...

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Day One Biopharmaceuticals, Inc. (DAWN)

16:01 06-03-2026

Bala Cynwyd, Pennsylvania--(Newsfile Corp. - March 6, 2026) - Law office of Brodsky & Smith announce...

Shareholder Alert: The Ademi Firm investigates whether Day One Biopharmaceuticals, Inc. is obtaining a Fair Price for its Public Shareholders

14:45 06-03-2026

MILWAUKEE, March 6, 2026 /PRNewswire/ -- Ademi LLP is investigating Day One (NASDAQ: DAWN) for possi...

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN)

13:12 06-03-2026

NEW YORK, March 6, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & As...

DAWN Stock Alert: Halper Sadeh LLC is Investigating Whether Day One Biopharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders

10:34 06-03-2026

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale ...

Day One Shares Surge After $2.5B Servier Deal

Výsledovka

Rozvaha

Peněžní toky

Nástroje

Ostatní

Profil

Podobné společnosti

Zahraniční články

Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN

Day One Biopharmaceuticals Touts OJEMDA Sales Surge, Sets $225M-$250M 2026 Outlook at TD Cowen

Are DAWN and TALK Obtaining Fair Deals for their Shareholders?

DAWN Stock Jumps 66% on $2.5B Buyout Offer From Servier

Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN

Stock Market Today, March 6: Energy Stocks Rise as Oil Closes Over $90 on Middle East Tensions

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Day One Biopharmaceuticals, Inc. (DAWN)

Shareholder Alert: The Ademi Firm investigates whether Day One Biopharmaceuticals, Inc. is obtaining a Fair Price for its Public Shareholders

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN)

DAWN Stock Alert: Halper Sadeh LLC is Investigating Whether Day One Biopharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders

Day One Shares Surge After $2.5B Servier Deal

Servier to buy Day One Biopharmaceuticals for total equity value of $2.5 billion

Servier and Day One Biopharmaceuticals announce acquisition to expand Servier's rare oncology portfolio

Day One Biopharmaceuticals: 'Strong Buy,' Several 2026 Milestones In Play Plus OJEMDA Growth

Day One Biopharmaceuticals, Inc. (DAWN) Reports Q4 Loss, Beats Revenue Estimates

Day One Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms 2026 Outlook and Revenue Guidance

Will Day One Biopharmaceuticals, Inc. (DAWN) Report Negative Earnings Next Week? What You Should Know

Day One To Report Fourth Quarter and Full-Year 2025 Financial Results Tuesday, February 24, 2026

Wall Street Analysts See a 101.08% Upside in Day One Biopharmaceuticals (DAWN): Can the Stock Really Move This High?

Best Momentum Stocks to Buy for January 27th

Výsledovka

Rozvaha

Peněžní toky